Zobrazeno 1 - 10
of 549
pro vyhledávání: '"John R. Nelson"'
Autor:
Amirmohammad Khalaji, Amir Hossein Behnoush, Yeganeh Pasebani, Ali Rafati, Tara Mahmoodi, Alireza Arzhangzadeh, Sima Shamshiri Khamene, Izat MohammadKhawajah, Mehdi Mehrani, Ali Vasheghani-Farahani, Farzad Masoudkabir, Kimia Najafi, Mani K. Askari, Anil Harrison, John R. Nelson, Kaveh Hosseini, Adrian V. Hernandez
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Triglyceride-glucose index (TyG), a surrogate marker of insulin resistance (IR), could be a potential prognostic marker in patients with acute coronary syndromes (ACS). We evaluated the effect of the TyG index on major adverse car
Externí odkaz:
https://doaj.org/article/a99532fca45f4e6ab99d78058c8184de
Autor:
John R. Nelson
The paths of different birds look like double helixes, flowing strands of hair, and migrating serpents, and they beckon with calls that have definite meanings. These mysterious creatures inspire growing numbers of birders in their passionate pursuit
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionCardiovascular (CV) disease remains a leading cause of mortality despite statin therapy. Statin add-on lipid-lowering therapies have been investigated for CV risk reduction, but their effect on CV mortality has not been reviewed.MethodsTh
Externí odkaz:
https://doaj.org/article/33f9c1e2416b4c2b89831e36bec30ea6
Autor:
Viet T. Le, Stacey Knight, Jeramie D. Watrous, Mahan Najhawan, Khoi Dao, Raymond O. McCubrey, Tami L. Bair, Benjamin D. Horne, Heidi T. May, Joseph B. Muhlestein, John R. Nelson, John F. Carlquist, Kirk U. Knowlton, Mohit Jain, Jeffrey L. Anderson
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionLong-chain omega-3 polyunsaturated fatty acids (OM3 PUFA) are commonly used for cardiovascular disease prevention. High-dose eicosapentaenoic acid (EPA) is reported to reduce major adverse cardiovascular events (MACE); however, a combined
Externí odkaz:
https://doaj.org/article/a44e80d84b8a40ba8d46716230f9431b
Autor:
Andrew J. Buckler, Gheorghe Doros, April Kinninger, Suvasini Lakshmanan, Viet T. Le, Peter Libby, Heidi T. May, Joseph B. Muhlestein, John R. Nelson, Anna Nicolaou, Sion K. Roy, Kashif Shaikh, Chandana Shekar, John A. Tayek, Luke Zheng, Deepak L. Bhatt, Matthew J. Budoff
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
AimsResidual cardiovascular risk persists despite statin therapy. In REDUCE-IT, icosapent ethyl (IPE) reduced total events, but the mechanisms of benefit are not fully understood. EVAPORATE evaluated the effects of IPE on plaque characteristics by co
Externí odkaz:
https://doaj.org/article/e28ba1e2c20049cd892822ca733eba9c
Autor:
ROPER, DON
Publikováno v:
New York History, 1988 Jan 01. 69(1), 119-120.
Externí odkaz:
https://www.jstor.org/stable/23178493
Autor:
Banning, Lance
Publikováno v:
The Georgia Historical Quarterly, 1988 Oct 01. 72(3), 545-547.
Externí odkaz:
https://www.jstor.org/stable/40581869
Autor:
Lindstrom, Diane
Publikováno v:
Pennsylvania History: A Journal of Mid-Atlantic Studies, 1990 Apr 01. 57(2), 214-216.
Externí odkaz:
https://www.jstor.org/stable/27773377
Autor:
Cochran, Thomas C.
Publikováno v:
The Pennsylvania Magazine of History and Biography, 1988 Oct 01. 112(4), 641-642.
Externí odkaz:
https://www.jstor.org/stable/20092268
Publikováno v:
American Heart Journal Plus, Vol 17, Iss , Pp 100148- (2022)
None of the clinical trials of omega-3 fatty acids using combinations of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were able to show any effect on cardiovascular outcomes, despite reductions in triglyceride levels. In contrast, the R
Externí odkaz:
https://doaj.org/article/d4f6e2ed98f14477a5e234d4dc1766de